Murphy Polly A.

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 32% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Murphy Polly A.'s trades of Atea Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2025-05-18
B Purchase
76,003 +21.8%
67.02
US$1,332,460 		76,003 +21.8% 67.02 US$1,332,460
2022-11-23 2022-11-22
US Celcuity Inc (CELC)
B Purchase
68,997 -26.3%
68.64
US$3,793,075 		68,997 -26.3% 68.64 US$3,793,075
2021-12-21 2021-12-20
B Purchase
30,066 -24.2%
238.31
US$2,873,524 		30,066 -24.2% 238.31 US$2,873,524